Previous 10 | Next 10 |
Amedisys, Inc. (AMED) Q4 2022 Earnings Conference Call February 16, 2023, 11:00 ET Company Participants Nick Muscato - Chief Strategy Officer Paul Kusserow - Chairman & CEO Scott Ginn - EVP, CFO & Acting COO Adam Holton - Chief People Officer Conferen...
The following slide deck was published by Amedisys, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Amedisys, Inc. 2022 Q4 - Results - Earnings Call Presentation
Amedisys ( NASDAQ: AMED ) said on Wednesday it had signed an agreement to divest its personal care division to HouseWorks inorder to focus on its Home Health, Hospice and High Acuity Care units. HouseWorks, in partnership with eCaring, provides mission critical software and ...
Amedisys press release ( NASDAQ: AMED ): Q4 Non-GAAP EPS of $1.16 beats by $0.18 . Revenue of $562.06M (+0.5% Y/Y) beats by $1.6M . 2023 Guidance Adjusted net service revenue is anticipated to be in the range of $2.244 billion to $2.274 billion vs $4.88 consensus. ...
BATON ROUGE, La., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2022. Three-Month Periods Ended December 31, 2022 and 2021 Net service revenue increased $2.7 mil...
NASHVILLE, Tenn., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Today, Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, announced a new agreement with BlueCross BlueShield of Tennessee to provide members in Middle Tennessee with palliative care in the comfort of...
BATON ROUGE, La., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, today announces that it has signed a definitive agreement to divest its Personal Care division to HouseWorks, LLC, a leading provider of personal car...
BATON ROUGE, La., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, today announced that its Board of Directors has authorized a stock repurchase program, under which the Company may repurchase ...
BATON ROUGE, La., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, has recognized 39 employees with the prestigious Spirit of Excellence Awards, one of the company’s highest honors. ...
BATON ROUGE, La., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the fourth quarter and year ended December 31, 2022, after the market closes on February 15, 2023. The...
News, Short Squeeze, Breakout and More Instantly...
Amedisys, Inc. (NASDAQ: AMED) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.74% on the day to $95.23. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates thr...
2024-05-27 23:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-08 00:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...